Developer docs
API playgroundTry for free, no card

Search company profiles

Kain Capital

Full company profile

uuid0008a4w

Namestring
Kain Capital
Legal namestring
Kain Capital, LLC
Websiteurl
kaincap.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Kain Capital is a New York-based private equity firm founded in 2015 by Kunal Kain that invests growth equity in founder-led, mid-sized U.S. healthcare companies with $20-150M+ in revenue and $5-40M in EBITDA. The firm targets five subsectors — primary care/multi-specialty, hospice/palliative care, diagnostic services, occupational medicine, and specialty behavioral health (autism therapy) — and typically takes control positions of 60-85% or protected minority positions of 20-49%, partnering with entrepreneurs who remain actively involved post-close.

The firm's defining feature is its technology enablement platform, Kain Analytics, a wholly-owned subsidiary launched in September 2024. Kain Analytics builds and deploys Python-based ETL pipelines, machine learning models (including CNNs, LLMs, and predictive analytics), NLP for clinical notes, and Power BI dashboards that consolidate payer data, EHR data (Epic, eClinicalWorks), and CMS claims into operational modules such as a Care Gaps framework, HCC recapture and risk-based contract management, risk stratification, payer transparency analytics, and operational/clinical intelligence. The firm also incubated Agenta Health, an agentic AI patient engagement platform combining inbound/outbound voice, text, and AI video, which was sold to Arbiter in 2025. Infrastructure runs on Azure and AWS with SQL Server, Plotly Dash, and Power BI for visualization.

Kain Capital generates revenue primarily through management fees and carried interest from healthcare-focused investment funds, with Kain Analytics providing a secondary stream of professional services revenue to portfolio companies. As of mid-2026, the portfolio includes MY DR NOW ($60M cumulative investment), Essen Health Care, Excelsior/Rendr, RadX Inc., White Wilson Medical Center, Luminos Hospice, Agile Occupational Medicine, ChenMed, MDLand, and an autism therapy platform — collectively spanning more than a dozen U.S. states. The firm is preparing for its inaugural institutional fund and has expanded leadership with senior hires including a CTO (Ashish Gupta, ex-Google ML lead), CFO/CCO (Bret Cummings), General Counsel (Solomon Eskinazi), and additional partners and VPs to support that launch.

Short descriptiontext

Kain Capital is a healthcare-focused growth private equity firm partnering with founder-led mid-sized healthcare companies across five subsectors, deploying proprietary technology enablement through Kain Analytics to drive value-based care transformation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, growth equity investing, healthcare technology enablement, value-based care analytics, healthcare services investment
Industry1 code
1Technology & Software Growth Equity
CodeFSANACAAPrimaryYes
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Management of Companies and Enterprises55111
SIC code2 codes
  • Investors, Nec6799
  • Finance Services6199
Product category
Healthcare Private Equity / Growth Equity Investing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Private Equity Fund Management
TypeSubscription Recurring
Description

Kain Capital operates as a private equity firm managing healthcare-focused investment funds. Revenue is generated through management fees and carried interest from portfolio company exits. The firm's investor base is comprised predominantly of long-term capital, permitting a patient approach to investing not tied to any specific return horizon.

kaincap.com
2Technology Enablement Services
TypeProfessional Services
Description

Kain Analytics, a subsidiary of Kain Capital, provides technology, data science and AI solutions to portfolio companies, generating service revenue through hands-on tech implementation including data stack development, value-based care quality pipelines, and technology consulting.

kaincap.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Kain Capital is a private equity firm that makes growth equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, typically taking control positions (60-85%) or protected minority positions (20-49%). The firm pairs capital with hands-on operational and technology enablement through its Kain Analytics subsidiary, which deploys proprietary AI/ML, data warehousing, and analytics modules to help portfolio companies transition to value-based care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 80-90% of manual patient engagement calls automated through Agenta Health AI platform
+6 more records
Product overview1 text field

Kain Capital operates as a private equity firm focused on healthcare services and technology-enabled healthcare companies. The firm's technology arm, Kain Analytics, provides centralized AI, data science, and workflow automation solutions across the portfolio. The product suite includes Agenta Health (AI-powered patient engagement platform), CMS Caregaps and Quality tracking, HCC Recapture and opportunity detection, Risk Stratification, Predictive Analytics for value-based care, Operational/Clinical Intelligence dashboards, and Payer Transparency analytics. These modules work together to enable portfolio companies' transition to value-based care through integrated EHR data processing, risk scoring, care gap management, and population health analytics.

Product and service2 records
1Kain Analytics
CategoryHealthcare analytics / technology enablement subsidiary
Description

Technology, data science, and AI subsidiary of Kain Capital that delivers centralized analytics, workflow automation, and custom-built implementations for healthcare portfolio companies, including EHR integration, value-based care pipelines, care gap and HCC management, risk stratification, predictive analytics, operational dashboards, and payer transparency tooling.

2Healthcare Growth Equity Investments
CategoryPrivate equity / growth equity fund
Description

Growth equity private equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, paired with operational support, senior management recruitment, strategic M&A, and Kain Analytics technology enablement to accelerate organic growth and transition portfolio companies to value-based care.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Agenta Health, the AI innovation arm of Kain Analytics, was sold to Arbiter in 2025. Arbiter is a care orchestration platform unifying patients, providers, and payers on one intelligent system, leveraging Agenta's agentic technology for patient, provider, and plan engagement. Agenta's technology now powers Arbiter's broader care orchestration mission.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused growth equity firm investing in lower middle market healthcare services and technology-enabled care companies. Highly comparable to Kain: similar mid-sized founder-led thesis, sector overlap in primary care and physician groups, and overlapping team pedigree (Kain Partner Sameer Mathur joined from Chicago Pacific Founders).

TypeDirect peer
Description

Lower middle market healthcare PE firm focused exclusively on healthcare services, healthcare IT, and medical products across North America. Directly comparable to Kain on sector exclusivity, deal-size sweet spot, and the operational/value-creation playbook. Kain Partner Sameer Mathur also previously worked at DW Healthcare Partners.

TypeDirect peer
Description

Healthcare-only middle-market PE firm making control and growth investments in healthcare services and products. Closely comparable to Kain on sector focus, equity check size range, and founder-friendly partnership orientation.

TypeDirect peer
Description

One of the longest-tenured healthcare-focused PE firms, investing across healthcare services, technology, and information services. Larger and more established than Kain but competes in the same sector and many of the same subsectors (physician groups, value-based care, healthcare IT).

TypeDirect peer
Description

Healthcare-focused growth equity firm with significant activity in healthcare services, payer-services, and tech-enabled care. Comparable to Kain on healthcare-services emphasis and growth equity orientation, though at substantially larger fund sizes.

TypeDirect peer
Description

Growth equity firm investing in lower middle market healthcare services and information technology companies. Highly comparable to Kain on healthcare-only mandate, mid-market check size, and tech-enabled services focus.

TypeDirect peer
Description

Middle-market PE firm with an active healthcare vertical that pursues control investments in founder-led healthcare services companies. Comparable to Kain on mid-sized founder-led thesis, healthcare services focus, and add-on roll-up strategy.

TypeBroad incumbent
Description

Large diversified alternative asset manager with a dedicated TPG Healthcare strategy that invests across healthcare services, pharma, and medtech. Competes with Kain for larger healthcare-services deals and provides a comparison point on scale and resources versus a focused mid-market specialist.

TypeBroad incumbent
Description

Global PE platform with a dedicated Bain Capital Life Sciences / healthcare services practice that invests across the healthcare value chain. Comparable as a competitor for mid- and upper-mid healthcare services opportunities, though operating at substantially larger scale than Kain.

TypeEmerging player
Description

Lower middle market PE firm investing in healthcare services, consumer, and B2B services companies. Smaller and earlier-stage than Kain but a relevant peer on healthcare services focus and lower-middle-market deal zone.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kain Capital

Healthcare Private Equity / Growth Equity Investingkaincap.com

Kain Capital is a healthcare-focused growth private equity firm partnering with founder-led mid-sized healthcare companies across five subsectors, deploying proprietary technology enablement through Kain Analytics to drive value-based care transformation.

What Kain Capital does

Kain Capital is a New York-based private equity firm founded in 2015 by Kunal Kain that invests growth equity in founder-led, mid-sized U.S. healthcare companies with $20-150M+ in revenue and $5-40M in EBITDA. The firm targets five subsectors — primary care/multi-specialty, hospice/palliative care, diagnostic services, occupational medicine, and specialty behavioral health (autism therapy) — and typically takes control positions of 60-85% or protected minority positions of 20-49%, partnering with entrepreneurs who remain actively involved post-close.

The firm's defining feature is its technology enablement platform, Kain Analytics, a wholly-owned subsidiary launched in September 2024. Kain Analytics builds and deploys Python-based ETL pipelines, machine learning models (including CNNs, LLMs, and predictive analytics), NLP for clinical notes, and Power BI dashboards that consolidate payer data, EHR data (Epic, eClinicalWorks), and CMS claims into operational modules such as a Care Gaps framework, HCC recapture and risk-based contract management, risk stratification, payer transparency analytics, and operational/clinical intelligence. The firm also incubated Agenta Health, an agentic AI patient engagement platform combining inbound/outbound voice, text, and AI video, which was sold to Arbiter in 2025. Infrastructure runs on Azure and AWS with SQL Server, Plotly Dash, and Power BI for visualization.

Kain Capital generates revenue primarily through management fees and carried interest from healthcare-focused investment funds, with Kain Analytics providing a secondary stream of professional services revenue to portfolio companies. As of mid-2026, the portfolio includes MY DR NOW ($60M cumulative investment), Essen Health Care, Excelsior/Rendr, RadX Inc., White Wilson Medical Center, Luminos Hospice, Agile Occupational Medicine, ChenMed, MDLand, and an autism therapy platform — collectively spanning more than a dozen U.S. states. The firm is preparing for its inaugural institutional fund and has expanded leadership with senior hires including a CTO (Ashish Gupta, ex-Google ML lead), CFO/CCO (Bret Cummings), General Counsel (Solomon Eskinazi), and additional partners and VPs to support that launch.

Kain Capital firmographics

Firmographics
Name
Kain Capital
Legal name
Kain Capital, LLC
Website
https://kaincap.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Kain Capital is a healthcare-focused growth private equity firm partnering with founder-led mid-sized healthcare companies across five subsectors, deploying proprietary technology enablement through Kain Analytics to drive value-based care transformation.
Ownership category
akta.pro rank

Kain Capital industry classification

Industry
Product category
Healthcare Private Equity / Growth Equity Investing
NAICS
Portfolio Management and Investment Advice (523940), Management of Companies and Enterprises (55111)
SIC
Investors, Nec (6799), Finance Services (6199)
akta.pro primary industry
Technology & Software Growth Equity (FSANACAA)

Keywords

  • Healthcare private equity
  • Growth equity investing
  • Healthcare technology enablement
  • Value-based care analytics
  • Healthcare services investment

Where Kain Capital is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Kain Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Private Equity Fund Management: Kain Capital operates as a private equity firm managing healthcare-focused investment funds. Revenue is generated through management fees and carried interest from portfolio company exits. The firm's investor base is comprised predominantly of long-term capital, permitting a patient approach to investing not tied to any specific return horizon.
  2. Technology Enablement Services: Kain Analytics, a subsidiary of Kain Capital, provides technology, data science and AI solutions to portfolio companies, generating service revenue through hands-on tech implementation including data stack development, value-based care quality pipelines, and technology consulting.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Kain Capital product offering

Product offering

Core offering

Kain Capital is a private equity firm that makes growth equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, typically taking control positions (60-85%) or protected minority positions (20-49%). The firm pairs capital with hands-on operational and technology enablement through its Kain Analytics subsidiary, which deploys proprietary AI/ML, data warehousing, and analytics modules to help portfolio companies transition to value-based care.

Product overview

Kain Capital operates as a private equity firm focused on healthcare services and technology-enabled healthcare companies. The firm's technology arm, Kain Analytics, provides centralized AI, data science, and workflow automation solutions across the portfolio. The product suite includes Agenta Health (AI-powered patient engagement platform), CMS Caregaps and Quality tracking, HCC Recapture and opportunity detection, Risk Stratification, Predictive Analytics for value-based care, Operational/Clinical Intelligence dashboards, and Payer Transparency analytics. These modules work together to enable portfolio companies' transition to value-based care through integrated EHR data processing, risk scoring, care gap management, and population health analytics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Kain Analytics Technology, data science, and AI subsidiary of Kain Capital that delivers centralized analytics, workflow automation, and custom-built implementations for healthcare portfolio companies, including EHR integration, value-based care pipelines, care gap and HCC management, risk stratification, predictive analytics, operational dashboards, and payer transparency tooling.
  • Healthcare Growth Equity Investments Growth equity private equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, paired with operational support, senior management recruitment, strategic M&A, and Kain Analytics technology enablement to accelerate organic growth and transition portfolio companies to value-based care.

Quantifiable outcome

  • 80-90% of manual patient engagement calls automated through Agenta Health AI platform
  • +6 more outcomes

Companies that use Kain Capital

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Kain Capital technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature7 records

Kain Capital partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ArbitercoreStrategic or Co-development Partner · 1 January 2025Agenta Health, the AI innovation arm of Kain Analytics, was sold to Arbiter in 2025. Arbiter is a care orchestration platform unifying patients, providers, and payers on one intelligent system, leveraging Agenta's agentic technology for patient, provider, and plan engagement. Agenta's technology now powers Arbiter's broader care orchestration mission.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Kain Capital competitors and assessment

Company assessment

Direct peers

  • Chicago Pacific Founders: Healthcare-focused growth equity firm investing in lower middle market healthcare services and technology-enabled care companies. Highly comparable to Kain: similar mid-sized founder-led thesis, sector overlap in primary care and physician groups, and overlapping team pedigree (Kain Partner Sameer Mathur joined from Chicago Pacific Founders).
  • DW Healthcare Partners: Lower middle market healthcare PE firm focused exclusively on healthcare services, healthcare IT, and medical products across North America. Directly comparable to Kain on sector exclusivity, deal-size sweet spot, and the operational/value-creation playbook. Kain Partner Sameer Mathur also previously worked at DW Healthcare Partners.
  • Linden Capital Partners: Healthcare-only middle-market PE firm making control and growth investments in healthcare services and products. Closely comparable to Kain on sector focus, equity check size range, and founder-friendly partnership orientation.
  • Welsh, Carson, Anderson & Stowe: One of the longest-tenured healthcare-focused PE firms, investing across healthcare services, technology, and information services. Larger and more established than Kain but competes in the same sector and many of the same subsectors (physician groups, value-based care, healthcare IT).
  • New Mountain Capital: Healthcare-focused growth equity firm with significant activity in healthcare services, payer-services, and tech-enabled care. Comparable to Kain on healthcare-services emphasis and growth equity orientation, though at substantially larger fund sizes.
  • Health Enterprise Partners: Growth equity firm investing in lower middle market healthcare services and information technology companies. Highly comparable to Kain on healthcare-only mandate, mid-market check size, and tech-enabled services focus.
  • Audax Group: Middle-market PE firm with an active healthcare vertical that pursues control investments in founder-led healthcare services companies. Comparable to Kain on mid-sized founder-led thesis, healthcare services focus, and add-on roll-up strategy.

Broad incumbents

  • TPG Capital: Large diversified alternative asset manager with a dedicated TPG Healthcare strategy that invests across healthcare services, pharma, and medtech. Competes with Kain for larger healthcare-services deals and provides a comparison point on scale and resources versus a focused mid-market specialist.
  • Bain Capital Private Equity (Healthcare): Global PE platform with a dedicated Bain Capital Life Sciences / healthcare services practice that invests across the healthcare value chain. Comparable as a competitor for mid- and upper-mid healthcare services opportunities, though operating at substantially larger scale than Kain.

Emerging players

  • Copley Equity Partners: Lower middle market PE firm investing in healthcare services, consumer, and B2B services companies. Smaller and earlier-stage than Kain but a relevant peer on healthcare services focus and lower-middle-market deal zone.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Kain Capital social profiles

Digital presence

Kain Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kain Capital leadership team

Management profile

Number of profiles

Profiles12 records

Kain Capital subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Kain Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kain Capital M&A and investment

M&A and investment

M&A3 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kain Capital

What does Kain Capital do?

Kain Capital is a private equity firm that makes growth equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, typically taking control positions (60-85%) or protected minority positions (20-49%). The firm pairs capital with hands-on operational and technology enablement through its Kain Analytics subsidiary, which deploys proprietary AI/ML, data warehousing, and analytics modules to help portfolio companies transition to value-based care.

Is Kain Capital a public or private company?

Kain Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Kain Capital founded?

Kain Capital was founded in 2015. It employs 11 to 50 people.

Where is Kain Capital based?

Kain Capital is headquartered in New York, United States, in the North America region.

How does Kain Capital make money?

Two revenue lines are on record. Private Equity Fund Management is the primary driver. The others are technology Enablement Services.

Who are Kain Capital's main competitors?

Direct peers on record are Chicago Pacific Founders, DW Healthcare Partners, Linden Capital Partners, Welsh, Carson, Anderson & Stowe, New Mountain Capital, Health Enterprise Partners and Audax Group. Broad incumbents are TPG Capital and Bain Capital Private Equity (Healthcare). Copley Equity Partners is listed as an emerging player.

Does Kain Capital have an API?

No public API is recorded for Kain Capital.

What industry is Kain Capital in?

Kain Capital's product category is Healthcare Private Equity / Growth Equity Investing. Its primary akta.pro industry code is FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523940 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0RadX Receives Investment From Kain Capital To Expand Outpatient Radiology PlatformKain Capital announced the completion of its investment in RadX Inc., an outpatient radiology platform operating a network of 26 independent imaging centers across Florida, Michigan, Maryland, Georgia, Tennessee, and Alabama. The investment is intended to support RadX's continued expansion across high-growth and underserved markets as demand for outpatient diagnostic imaging services continues to increase. RadX plans to use the funds to expand its clinic footprint, recruit additional physicians and operational personnel, invest in technology and patient experience initiatives, and pursue strategic growth opportunities in both existing and adjacent markets.FinSMEsRadX Receives Investment From Kain CapitalRadX Inc., a Florida-based outpatient radiology clinic operator, received an undisclosed investment from Kain Capital. The funds will support clinic expansion, technology investment, and patient experience initiatives. RadX operates 26 locations across six states.citybizKain Capital Invests in RadX to Expand Multi-State Outpatient Imaging PlatformKain Capital invested in RadX Inc., an outpatient radiology operator, to support its expansion across multiple U.S. markets. The investment aims to fund clinic growth, technology upgrades, and strategic initiatives amid increasing demand for outpatient diagnostic imaging.Business Wire BlogKain Capital Completes Investment in RadX Inc., a Leading Radiology PlatformKain Capital completed its investment in RadX Inc., a radiology services provider with 26 clinics across six U.S. states, aimed at expanding its outpatient imaging platform. The investment will support RadX’s growth in clinic footprint, talent acquisition, and technology enhancements, leveraging industry trends toward outpatient care and early disease detection.JD SupraHealthcare & Life Sciences Private Equity Deal Tracker: Kain Capital Acquires White WilsonKain Capital has announced its acquisition of White Wilson Medical Center, an independent multi-specialty physician group founded in 1946 and based in Fort Walton Beach, Florida. The practice operates nine clinic locations with more than 70 providers serving Florida's Emerald Coast. Kain Capital, a New York-based private equity firm founded in 2014 focused on healthcare services and technology investments, did not disclose the terms of the acquisition.citybizKain Capital Invests In White Wilson Medical Center and Appoints Brad Logan as CEOKain Capital LLC announced the completion of its investment in White Wilson Medical Center, P.A., the Emerald Coast\u2019s largest independent multi-specialty physician group, with Brad Logan appointed as Chief Executive Officer. The investment will support provider recruitment, clinic expansion, and geographic growth across the Florida Panhandle, while accelerating White Wilson\u2019s transition toward value-based care through its recently executed ACO REACH agreement. This transaction represents Kain Capital\u2019s fifth commitment in the primary care and multi-specialty sector.BeckersascPrivate equity firm acquires majority stake in independent physician groupKain Capital, a private equity firm, has acquired a majority stake in White Wilson Medical Center, an independent physician group based in Fort Walton Beach, Florida. The investment will support provider recruitment, clinic expansion, and geographic growth across Florida while funding the organization's transition to value-based care. Brad Logan, formerly CEO of US Eye and COO of Complete Health, has been appointed CEO of White Wilson Medical Center, which operates nine clinics serving more than 95,000 patients annually.National TodayKain Capital Invests in White Wilson Medical Center, Names Brad Logan as CEOKain Capital, a New York-based private equity firm, has completed an investment in White Wilson Medical Center, acquiring a majority stake in the Florida healthcare provider. As part of the deal completed on March 30, 2026, Brad Logan has been appointed as the new CEO, replacing the previous leadership team. The transaction is subject to customary regulatory approvals, and the new leadership is expected to focus on expanding the provider's service offerings and improving operational efficiency.ThehealthcareinvestorHealthcare & Life Sciences Private Equity Deal Tracker: Kain Capital Acquires White WilsonKain Capital, a New York-based private equity firm founded in 2014, has announced its acquisition of White Wilson Medical Center, an independent multi-specialty physician group. White Wilson, founded in 1946 and based in Fort Walton Beach, Florida, operates nine clinic locations with more than 70 providers serving Florida's Emerald Coast. Terms of the acquisition were not disclosed.YahooKain Capital Expands Investment and Strategy Leadership with Hiring of Sameer Mathur as Partner and Bridie Gahan as Vice President of StrategyKain Capital LLC, a private equity firm focused on healthcare services and technology-enabled healthcare companies, announced the appointments of Sameer Mathur as Partner and Bridie Gahan as Vice President of Strategy. Sameer Mathur brings over 16 years of principal investing experience across healthcare and technology-enabled services, most recently from Chicago Pacific Founders, while Bridie Gahan joins from Astrana Health's value-based care ecosystem. The firm stated these additions strengthen its investment and operational leadership as it prepares for its inaugural institutional fund.